Pathology re-review as an essential component of breast cancer management.
作者信息
Kleer C G
出版信息
Curr Oncol. 2010 Feb;17(1):2-3. doi: 10.3747/co.v17i1.517.
Abstract
摘要
相似文献
1
Pathology re-review as an essential component of breast cancer management.病理复查作为乳腺癌管理的重要组成部分。
Curr Oncol. 2010 Feb;17(1):2-3. doi: 10.3747/co.v17i1.517.
2
Predictors of re-excision in wire-guided wide local excision for early breast cancer: a Western Australian multi-centre experience.早期乳腺癌金属丝引导下局部广泛切除术后再次切除的预测因素：西澳大利亚多中心经验
ANZ J Surg. 2015 Jul-Aug;85(7-8):540-5. doi: 10.1111/ans.13067. Epub 2015 Apr 16.
3
4
Impact of routine pathology review on treatment for node-negative breast cancer.常规病理复查对淋巴结阴性乳腺癌治疗的影响。
J Clin Oncol. 2012 Jun 20;30(18):2227-31. doi: 10.1200/JCO.2011.38.9247. Epub 2012 May 7.
5
Impact of systematic cavity shave margins in breast-conserving surgery at a large community hospital with a low baseline re-excision rate.在一个低基线再次切除率的大型社区医院中，保乳手术中系统性切缘空腔刮除的影响。
Breast J. 2020 Oct;26(10):1960-1965. doi: 10.1111/tbj.14057. Epub 2020 Oct 19.
6
Predictive factors for residual disease in re-excision specimens after breast-conserving surgery.保乳手术后再次切除标本中残留疾病的预测因素。
Breast J. 2012 Jul-Aug;18(4):339-44. doi: 10.1111/j.1524-4741.2012.01249.x. Epub 2012 May 23.
7
Results of re-excisional biopsy of the primary tumor in preparation for definitive irradiation of patients with early stage breast cancer.
Int J Radiat Oncol Biol Phys. 1986 May;12(5):721-5. doi: 10.1016/0360-3016(86)90028-3.
8
Predictors of Residual Disease After Breast Conservation Surgery.保乳手术后残留疾病的预测因素。
Ann Surg Oncol. 2018 Jul;25(7):1936-1942. doi: 10.1245/s10434-018-6454-1. Epub 2018 May 10.
9
Resection margins in ultrasound-guided breast-conserving surgery.超声引导下保乳手术中的切缘。
Ann Surg Oncol. 2011 Feb;18(2):447-52. doi: 10.1245/s10434-010-1280-0. Epub 2010 Aug 24.
10
Atypical ductal hyperplasia at margin of breast biopsy--is re-excision indicated?乳腺活检边缘的非典型导管增生——是否需要再次切除？
Ann Surg Oncol. 2008 Mar;15(3):843-7. doi: 10.1245/s10434-007-9681-4. Epub 2007 Nov 7.
本文引用的文献
1
Inter-institutional pathology consultations for breast cancer: impact on clinical oncology therapy recommendations.医疗机构间乳腺癌病理会诊对临床肿瘤学治疗建议的影响。
Curr Oncol. 2010 Feb;17(1):25-32. doi: 10.3747/co.v17i1.461.
2
Cancer statistics, 2007.2007年癌症统计数据。
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. doi: 10.3322/canjclin.57.1.43.
3
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.美国临床肿瘤学会/美国病理学家学会关于乳腺癌中人表皮生长因子受体2检测的指南建议
J Clin Oncol. 2007 Jan 1;25(1):118-45. doi: 10.1200/JCO.2006.09.2775. Epub 2006 Dec 11.
4
Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board.乳腺癌多学科肿瘤委员会病例审查导致的手术管理变化。
Cancer. 2006 Nov 15;107(10):2346-51. doi: 10.1002/cncr.22266.
5
The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience.多学科乳腺癌中心对患者管理建议的影响：宾夕法尼亚大学的经验
Cancer. 2001 Apr 1;91(7):1231-7. doi: 10.1002/1097-0142(20010401)91:7<1231::aid-cncr1123>3.0.co;2-k.
6
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.通过免疫组织化学检测雌激素受体状态在预测乳腺癌辅助内分泌治疗反应方面优于配体结合测定法。
J Clin Oncol. 1999 May;17(5):1474-81. doi: 10.1200/JCO.1999.17.5.1474.
Zotero 插件